These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 12152675)
1. Atorvastatin and thrombogenicity of the carotid atherosclerotic plaque: the ATROCAP study. Cortellaro M; Cofrancesco E; Arbustini E; Rossi F; Negri A; Tremoli E; Gabrielli L; Camera M Thromb Haemost; 2002 Jul; 88(1):41-7. PubMed ID: 12152675 [TBL] [Abstract][Full Text] [Related]
2. Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques. Durán MC; Martín-Ventura JL; Mohammed S; Barderas MG; Blanco-Colio LM; Mas S; Moral V; Ortega L; Tuñón J; Jensen ON; Vivanco F; Egido J Eur J Pharmacol; 2007 May; 562(1-2):119-29. PubMed ID: 17336287 [TBL] [Abstract][Full Text] [Related]
3. Blood-borne tissue factor activity predicts major cerebrovascular events in patients undergoing carotid endarterectomy: results from a 1-year follow-up study. Krupinski J; Turu MM; Font MA; Catena E; Slevin M; Morchon S; Rubio F; Badimon L; Martínez-González J Cerebrovasc Dis; 2008; 25(1-2):32-9. PubMed ID: 18033956 [TBL] [Abstract][Full Text] [Related]
4. One-year atorvastatin treatment in hypercholesterolemic patients with or without carotid artery disease. Avellone G; Di Garbo V; Abruzzese G; Campisi D; De Simone R; Raneli G; Licata G Int Angiol; 2006 Mar; 25(1):26-34. PubMed ID: 16520721 [TBL] [Abstract][Full Text] [Related]
5. Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study. Macin SM; Perna ER; Farías EF; Franciosi V; Cialzeta JR; Brizuela M; Medina F; Tajer C; Doval H; Badaracco R Am Heart J; 2005 Mar; 149(3):451-7. PubMed ID: 15864233 [TBL] [Abstract][Full Text] [Related]
6. Composition of coronary plaques obtained by directional atherectomy in stable angina: its relation to serum lipids and statin treatment. Solem J; Levin M; Karlsson T; Grip L; Albertsson P; Wiklund O J Intern Med; 2006 Mar; 259(3):267-75. PubMed ID: 16476104 [TBL] [Abstract][Full Text] [Related]
7. Decreased circulating Fas ligand in patients with familial combined hyperlipidemia or carotid atherosclerosis: normalization by atorvastatin. Blanco-Colio LM; Martín-Ventura JL; Sol JM; Díaz C; Hernández G; Egido J J Am Coll Cardiol; 2004 Apr; 43(7):1188-94. PubMed ID: 15063428 [TBL] [Abstract][Full Text] [Related]
8. Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma. Hothersall EJ; Chaudhuri R; McSharry C; Donnelly I; Lafferty J; McMahon AD; Weir CJ; Meiklejohn J; Sattar N; McInnes I; Wood S; Thomson NC Thorax; 2008 Dec; 63(12):1070-5. PubMed ID: 18757458 [TBL] [Abstract][Full Text] [Related]
9. Dyslipidemia shifts the tissue factor/tissue factor pathway inhibitor balance toward increased thrombogenicity in atherosclerotic plaques: evidence for a corrective effect of statins. Zawadzki C; Susen S; Richard F; Haulon S; Corseaux D; Jeanpierre E; Vincentelli A; Lucas C; Torpier G; Martin A; Van Belle E; Staels B; Jude B Atherosclerosis; 2007 Dec; 195(2):e117-25. PubMed ID: 17196206 [TBL] [Abstract][Full Text] [Related]
10. Effects of increasing doses of atorvastatin on the atherogenic lipid subclasses commonly associated with hypertriglyceridemia. Karalis DG; Ishisaka DY; Luo D; Ntanios F; Wun CC Am J Cardiol; 2007 Aug; 100(3):445-9. PubMed ID: 17659926 [TBL] [Abstract][Full Text] [Related]
11. Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets? Piorkowski M; Fischer S; Stellbaum C; Jaster M; Martus P; Morguet AJ; Schultheiss HP; Rauch U J Am Coll Cardiol; 2007 Mar; 49(10):1035-42. PubMed ID: 17349882 [TBL] [Abstract][Full Text] [Related]
12. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial. Tsimikas S; Witztum JL; Miller ER; Sasiela WJ; Szarek M; Olsson AG; Schwartz GG; Circulation; 2004 Sep; 110(11):1406-12. PubMed ID: 15353498 [TBL] [Abstract][Full Text] [Related]
13. E-selectin and TFPI are associated with carotid intima-media thickness in stable IHD patients: the baseline findings of the MIAMI study. Porta B; Baldassarre D; Camera M; Amato M; Arquati M; Brusoni B; Fiorentini C; Montorsi P; Romano S; Tremoli E; Cortellaro M; Nutr Metab Cardiovasc Dis; 2008 May; 18(4):320-8. PubMed ID: 17889518 [TBL] [Abstract][Full Text] [Related]
14. The effect of rapid lipid lowering with atorvastatin on autonomic parameters in patients with coronary artery disease. Szramka M; Harriss L; Ninnio D; Windebank E; Brack J; Skiba M; Krum H Int J Cardiol; 2007 Apr; 117(2):287-91. PubMed ID: 16889854 [TBL] [Abstract][Full Text] [Related]
15. Circulating monocytes mirror the imbalance in TF and TFPI expression in carotid atherosclerotic plaques with lipid-rich and calcified morphology. Basavaraj MG; Sovershaev MA; Egorina EM; Gruber FX; Bogdanov VY; Fallon JT; Østerud B; Mathiesen EB; Hansen JB Thromb Res; 2012 Apr; 129(4):e134-41. PubMed ID: 22178066 [TBL] [Abstract][Full Text] [Related]
17. Randomised study to compare the efficacy and safety of isapgol plus atorvastatin versus atorvastatin alone in subjects with hypercholesterolaemia. Jayaram S; Prasad HB; Sovani VB; Langade DG; Mane PR J Indian Med Assoc; 2007 Mar; 105(3):142-5, 150. PubMed ID: 17824470 [TBL] [Abstract][Full Text] [Related]
18. Pregnancy-associated plasma protein-A elevation in patients with acute coronary syndrome and subsequent atorvastatin therapy. Miedema MD; Conover CA; MacDonald H; Harrington SC; Oberg D; Wilson D; Henry TD; Schwartz RS Am J Cardiol; 2008 Jan; 101(1):35-9. PubMed ID: 18157962 [TBL] [Abstract][Full Text] [Related]
19. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging. Yonemura A; Momiyama Y; Fayad ZA; Ayaori M; Ohmori R; Higashi K; Kihara T; Sawada S; Iwamoto N; Ogura M; Taniguchi H; Kusuhara M; Nagata M; Nakamura H; Tamai S; Ohsuzu F J Am Coll Cardiol; 2005 Mar; 45(5):733-42. PubMed ID: 15734619 [TBL] [Abstract][Full Text] [Related]
20. The effect of atorvastatin on heart rate variability and lipoproteins in patients treated with coronary bypass surgery. Riahi S; Schmidt EB; Amanavicius N; Karmisholt J; Jensen HS; Christoffersen RP; Niebuhr U; Christensen JH; Toft E Int J Cardiol; 2006 Aug; 111(3):436-41. PubMed ID: 16290290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]